Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123431216 | 12343121 | 6 | F | 20160424 | 20160707 | 20160506 | 20160711 | EXP | US-GLAXOSMITHKLINE-US2016063805 | GLAXOSMITHKLINE | 70.67 | YR | F | Y | 0.00000 | 20160711 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123431216 | 12343121 | 1 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 2 PUFF(S), BID | U | UNKNOWN | 0 | 2 | DF | INHALATION POWDER | BID | ||||
| 123431216 | 12343121 | 2 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID | U | 0 | 1 | DF | INHALATION POWDER | BID | |||||
| 123431216 | 12343121 | 3 | PS | INCRUSE ELLIPTA | UMECLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 2 PUFF(S), BID | U | UNKNOWN | 205382 | 2 | DF | INHALATION POWDER | BID | ||||
| 123431216 | 12343121 | 4 | SS | INCRUSE ELLIPTA | UMECLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 1 PUFF(S), 1D | U | 205382 | 1 | DF | INHALATION POWDER | QD | |||||
| 123431216 | 12343121 | 5 | SS | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | U | 0 | |||||||||||
| 123431216 | 12343121 | 6 | C | GABAPENTIN. | GABAPENTIN | 1 | U | 0 | |||||||||||
| 123431216 | 12343121 | 7 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 123431216 | 12343121 | 8 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123431216 | 12343121 | 1 | Chronic obstructive pulmonary disease |
| 123431216 | 12343121 | 2 | Emphysema |
| 123431216 | 12343121 | 3 | Chronic obstructive pulmonary disease |
| 123431216 | 12343121 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123431216 | 12343121 | OT |
| 123431216 | 12343121 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123431216 | 12343121 | Confusional state | |
| 123431216 | 12343121 | Drug hypersensitivity | |
| 123431216 | 12343121 | Malaise | |
| 123431216 | 12343121 | Pneumonia viral | |
| 123431216 | 12343121 | Prescribed overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |